Insights into RAS-driven melanoma and its therapeutic implications.

Intraepithelial Penile Lesions.

Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Identification of a novel PRUNE2::NTRK2 gene fusion in soft tissue sarcoma patients-friend or foe? Case series.

Radiotherapy of sinonasal cancers: 2025 update.

Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023.

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Consider the unexpected! An overlooked, elusive, rare but dramatic diagnosis: anorectal melanoma.

Association between ovarian sex cord-stromal tumors and non-hormone-sensitive cancers: A nationwide nested cohort study.

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study.

Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE.

Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma.

Novel Variants in Medium and Low Penetrance Predisposing Genes in a Hungarian Malignant Melanoma Cohort With Increased Risk.

Diagnostic trajectories of patients with rare cancer in the Netherlands: results from a nationwide cross-sectional survey.

Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1-Associated Genes in Finnish Patients with Uveal Melanoma.

Protein-truncating and rare missense variants in ATM and CHEK2 and associations with cancer in UK Biobank whole-exome sequence data.

Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia.

Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.

Skin Changes in Suspected Lyme Disease.

Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.

Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome.

Quality indicators: completeness, validity and timeliness of cancer registry data contributing to the European Cancer Information System.

Genomic profiling of a metastatic anaplastic melanocytic neuroectodermal tumor arising from a mature thymic teratoma as part of a mediastinal germ cell tumor.

'Get Data Out' Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England.

CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study.

The Transcriptional Landscape of BRAF Wild Type Metastatic Melanoma: A Pilot Study.

Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.

Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel.

Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.

Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines.

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.

European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN.

Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma.

Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature.

Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.

A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors.

The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates.

Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer.

Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013.

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.

Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands - A nationwide population-based study.

Ano-uro-genital mucosal melanoma UK national guidelines.

Germline loss-of-function variants in MBD4 are rare in Finnish patients with uveal melanoma.

Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort.

Incidence and Survival of Patients With Conjunctival Melanoma in Europe.

Phase 2 study of pembrolizumab in patients with advanced rare cancers.

Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents.

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.

A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma.

Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.

Genetic epidemiology of colorectal cancer and associated cancers.

Familial aggregation of early-onset cancers.

Combined analysis of keratinocyte cancers identifies novel genome-wide loci.

Comparison of quality of life between melanoma and non-melanoma skin cancer patients.

Population-based analysis of BAP1 germline variations in patients with uveal melanoma.

Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors.

Risk of cancer in children and young adults conceived by assisted reproductive technology.

POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population.

Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.

Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.

Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.

Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.

Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria.

Pediatric patients with cutaneous melanoma: A European study.

Treatment of conjunctival melanoma in a Dutch referral centre.

Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP).

Lessons of a day hospital: Comprehensive assessment of patients with albinism in a European setting.

Ultrasound-based follow-up does not increase survival in early-stage melanoma patients: A comparative cohort study.

Satisfaction of mountain guides with high sun protection as a tool to prevent non-melanoma skin cancer.

Sinonasal mucosal melanoma: A 44-case study and literature analysis.

Do outdoor workers know their risk of NMSC? Perceptions, beliefs and preventive behaviour among farmers, roofers and gardeners.

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.

Risk of other Cancers in Families with Melanoma: Novel Familial Links.

Prognostic value of two tumour staging classifications in patients with sinonasal mucosal melanoma.

The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma.

Associations between childhood height and morphologically different variants of melanoma in adulthood.

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers.

Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.

The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.

A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.

Trends in survival for teenagers and young adults with cancer in the UK 1992-2006.

Comparison of melanoma incidence and trends among youth under 25 years in Australia and England, 1990-2010.

High nevus counts confer a favorable prognosis in melanoma patients.

Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition.

443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011.

The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations.

Sinonasal malignancies in Sweden 1960-2010; a nationwide study of the Swedish population.

Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers.

The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.